Navigation Links
New Topical Patent Research Reports Recently Published at MarketPublishers.com
Date:12/27/2010

LONDON, Dec. 27, 2010 /PRNewswire/ -- Market Publishers Ltd informs that new in-demand market reports featuring drugs patent researches have been added to its catalogue "Drugs & Biotechnology."

Each of the recently published reports is a regularly updated, professional patent search which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.

New market patent research reports include:

  • Sevelamer - Comprehensive Patent Search
  • Sildenafil - Comprehensive Patent Search
  • Silodosin - Comprehensive Patent Search
  • Sorafenib - Comprehensive Patent Search
  • Sunitinib - Comprehensive Patent Search
  • Tadalafil - Comprehensive Patent Search
  • Tazobactam - Comprehensive Patent Search
  • Tenofovir - Comprehensive Patent Search
  • Terbinafine - Comprehensive Patent Search
  • Ulipristal - Comprehensive Patent Search
  • Valaciclovir - Comprehensive Patent Search
  • Varenicline - Comprehensive Patent Search
  • Voriconazole - Comprehensive Patent Search

  • Each Patent Search features:

  • Comprehensive patent searching, covering the world's key territories;
  • Identifies patents covering molecule, formulation, process, use, combination and assay techniques;
  • Patent identification, categorisation and interpretation;
  • Grouped by patent family and assigned to development categories based on Interpretation of key aspects of the patent claims;
  • Manual filtration of patents not relevant to generic development;
  • Updated on a monthly basis, including changes to patent families, statuses, and litigation;
  • Enables fast analysis and verification by hyper-linking to crucial patent documents and national registers.

  • Patent categories identified in each report encompass molecular form, active ingredient preparation, formulations & methods thereof, related medical use & administration, active ingredient combinations, analytical methods.

    More new recent market research reports on Drugs & Biotechnology can be found at http://marketpublishers.com/catalog/drugs_biotechnology.htmlCONTACTSThe Market Publishers, Ltd.Mrs. Alla MartinTel: +44 208 123 2220Fax: +44 207 900 3970ps@marketpublishers.comwww.marketpublishers.com
    '/>"/>

    SOURCE The Market Publishers, Ltd.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Xenon Pharmaceuticals Initiates a Phase 2 Clinical Trial in Post Herpetic Neuralgia (PHN) for Topical XEN402.
    2. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
    3. Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds
    4. Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday, October 6, 2009 to Announce Top-Line Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel(R)
    5. Topical erectile dysfunction therapy shows promise
    6. Hygeia Therapeutics Signs an Exclusive License with Yale University for Potent, Safe Topical Anti-Androgens
    7. Innocoll Announces Provisional Findings From Its Three Phase 2 Clinical Trials Investigating CollaRx(R) GENTAMICIN TOPICAL for the Treatment and Prevention of Diabetic Foot Infections
    8. Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
    9. Cerimon Pharmaceuticals Initiates Phase III Clinical Studies to Evaluate Its Topical Diclofenac Sodium Patch for Mild-to-Moderate Pain
    10. Pilot Study Finds Adding Topical Imiquimod To Laser Therapy Improves The Response Of Port Wine Stain Birthmarks
    11. Sigma-Aldrich Signs Exclusive Agreement With IsoSciences, LLC, to Distribute Isotopically Labeled Bioactive Compounds
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/11/2017)... ... August 11, 2017 , ... “There is an ... natural alternatives to synthetic ingredients,” said Matt Hundt, President of Third Wave Bioactives. ... manufacturing presence and know-how of Biorigin will allow us to bring truly novel ...
    (Date:8/10/2017)... Ca (PRWEB) , ... August 09, 2017 , ... ... for regenerative medicine applications in the clinic is here. The team at Capricor ... present in conditioned medium for clinical studies. , Dr. Travis Antes, head ...
    (Date:8/10/2017)... (PRWEB) , ... August 09, 2017 , ... ... with four international biomedical optics laboratories — the Wellman Center for Photomedicine, the ... Laser Center Lübeck and the Beckman Laser Institute at University of California, Irvine ...
    (Date:8/10/2017)... (PRWEB) , ... August 10, 2017 , ... ... the stock market news outlet had initiated coverage on Next Group Holdings, Inc. ... and underserved consumer markets geared toward those that cannot engage in traditional banking ...
    Breaking Biology Technology:
    (Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
    (Date:3/30/2017)... LOS ANGELES , March 30, 2017  On ... Hack the Genome hackathon at ... This exciting two-day competition will focus on developing health ... experience. Hack the Genome is ... has been tremendous. The world,s largest companies in the ...
    (Date:3/29/2017)...  higi, the health IT company that operates the ... , today announced a Series B investment from ... The new investment and acquisition accelerates higi,s strategy to ... population health activities through the collection and workflow integration ... collects and secures data today on behalf of over ...
    Breaking Biology News(10 mins):